Allergic sensitization and filaggrin variants predispose to the comorbidity of eczema, asthma, and rhinitis: results from the Isle of Wight birth cohort

Abstract

Background Allergic sensitization and filaggrin gene (FLG) variants are important risk factors for allergic disorders; however, knowledge on their individual and interactive effects on the coexistence of eczema, asthma, and rhinitis is lacking. Objective This study aimed at investigating the single and combined effects of allergic sensitization and FLG variants on the development of single and multiple allergic disorders. Methods The Isle of Wight Birth Cohort (n = 1,456) has been examined at 1, 2, 4, 10, and 18 years of age. Repeated measurements of eczema, asthma, rhinitis, and skin prick tests were available for all follow-ups. FLG variants were genotyped in 1,150 participants. Associations of allergic sensitization and FLG variants with single and multiple allergic disorders were tested in log-binomial regression analysis. Results The prevalence of eczema-, asthma-, and rhinitis-only ranged from 5.6% to 8.5%, 4.9% to 10.2%, and 2.5% to 20.4%, respectively, during the first 18 years of life. The coexistence of allergic disorders is common, with approximately 2% of the population reporting the comorbidity of “eczema, asthma, and rhinitis” during the study period. In repeated measurement analyses, allergic sensitization and FLG variants, when analyzed separately, were associated with having single and multiple allergic disorders. Of particular significance, their combined effect increased the risk of “eczema and asthma” (RR = 13.67, 95% CI: 7.35 – 25.42), “asthma and rhinitis” (RR = 7.46, 95% CI: 5.07 – 10.98), and “eczema, asthma, and rhinitis” (RR = 23.44, 95% CI: 12.27 – 44.78). Conclusions and Clinical Relevance The coexistence of allergic disorders is frequent and allergic sensitization and FLG variants jointly increased risk of allergic comorbidities, which may represent more severe and complex clinical phenotypes. The interactive effect and the elevated proportion of allergic comorbidities associated with allergic sensitization and FLG variants emphasize their joint importance in the pathogenesis of allergic disorders.

Allergic disease and Staphylococcus aureus carriage in adolescents in the Arctic region of Norway

“…The lifetime prevalence for having any allergic disease was 45.1 %. Compared to the Swedish BAMSE study (4), the British IOW study (2) and the German MAS study (3), the prevalence of allergic disease in our population is close to the findings in…”

“…In the IoW study, there are higher prevalence for asthma, AR and multimorbidity (2). Variations in prevalence rates may be due to regional differences, but may partially also be due to different outcome definitions.…”

“…Prevalence of allergic diseases in the Tromsø study Fit Futures 2 compared to studies from Sweden (4), Germany (3) and United Kingdom(2). Total prevalence is adjusted for different participation rate among men and women.…”

Filaggrin mutations increase allergic airway disease in childhood and adolescence through interactions with eczema and aeroallergen sensitization

“…(21) With the same cohort, we further analysed the impact of FLG -LOF mutations on long-term allergic airway disease outcomes up to 18 years old, with eczema and aeroallergen sensitization as intermediate analysis variables. Using path analysis, the relative contributions of eczema and AAS towards the pathogenesis of asthma and rhinitis in FLG variants were evaluated.…”

Cutaneous exposure to clinically-relevant pigeon pea (Cajanus cajan) proteins promote TH2-dependent sensitization and IgE-mediated anaphylaxis in Balb/c mice

“…Structural abnormalities/ impaired function of filaggrin results in a defective barrier, and could be a potential risk factor in the allergic sensitization through the skin. Impairment in filaggrin (due to gene defect) is commonly associated with various allergic diseases like AD, FA, AR as well as allergic asthma (Valdman-Grinshpoun et al 2012;Ziyab et al 2014). Certain T H 2 cytokines like IL-4 and IL-13 may modulate filaggrin expression; thus, changes in their expression may ultimately lead to skin barrier dysfunction (Howell et al 2009).…”